Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 24, 2001

View Archived Issues

Study In Twins Points To Role Of Genetic Heart Disease Factors

London Exchange Might Ease Listing Rules For Young Firms

GPC, Byk Gulden Collaborate In Deal Worth Up To US$100M

European Bioethics Committee Starts Work, Elects President

Belgian Firms Tibotec, Virco Plan To Add Mass Via Merger

Strong Placebo Effect In Phase II Causes Failed Phytopharm Trial

IsoTis Completes Implants Of Autologous Living Bone Tissue

European Pharma Industry Calls For New Evaluation Structure

Other News To Note

Biotran Completes Australian IPO To Fund Diagnostics, HIV Product

NiCox Reveals 'Aggressive' Plan For Compounds In Coming Year

Cerep, Four European Companies Align To Create Compound Library

Genset Subscribes To Celera Products For Genomics Work

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...